LAMP1 and B-cell chronic lymphocytic leukemia: However, when comparing the degranulation capacity of CLL-derived NK cells by measuring CD107a expression we found a significant increase if the donating CLL patient was considered SLAMFhigh (Fig. 6c, SLAMFhigh = 6, SLAMFlow = 8 patients; p = 0.0033).